Rheumatology Network Newsletter

To view this email as a web page, click here.

GCA Affects Black and White Patients Equally

A study published in JAMA Ophthalmology shows that giant cell arteritis affects black and white patients equally, despite previous reports that suggest the condition is relatively rare in black patients.

JAK1 Filgotinib Promising for Rheumatoid Arthritis

The JAK1 inhibitor filgotinib has been shown to be effective in rheumatoid arthritis patients who failed previous treatment with one or more biologic DMARD.

Anti-TNF Roundup: The latest on these treatments for autoimmune conditions

In this slideshow we provide a quick update on the latest developments the anti-TNF treatments of rheumatoid arthritis, psoriatic arthrhitis, ankylosing spondylitis and other autoimmune conditions. Among the developments includes a new surprising use for etanercept (Enbrel, Amgen).

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.